What is the optimal time to perform a hearing assessment in newborns?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Optimal Timing for Newborn Hearing Assessment

All newborns should have hearing screening performed no later than 1 month of age, with comprehensive audiological evaluation by 3 months for those who fail the initial screening, and appropriate intervention by 6 months for those with confirmed hearing loss. 1

Recommended Screening Timeline

The Joint Committee on Infant Hearing (JCIH) provides clear guidelines on the optimal timing for newborn hearing assessment:

  1. Initial Screening: Before 1 month of age

    • Should be performed before discharge from the birth hospital
    • The 4th day of life shows the lowest referral rates (6%) and highest pass rates (94%) 2
    • Two-stage screening protocols (OAE followed by ABR) provide better specificity than single-stage testing 1
  2. Follow-up for Failed Screening: Before 3 months of age

    • Children who fail in-hospital screening are typically referred for repeat testing between 2-8 weeks after discharge 1
    • Diagnostic ABR testing can be performed as early as 3 months of age 1
  3. Intervention for Confirmed Hearing Loss: Before 6 months of age

    • For families choosing amplification, hearing aids should be fitted within 1 month of diagnosis 1

Screening Methods by Age

Different hearing assessment methods are appropriate at different ages:

  • Newborns to 9 months:

    • Otoacoustic emissions (OAE) and/or auditory brainstem response (ABR)
    • NICU infants admitted for more than 5 days should have ABR included in their screening 1
  • 9 months to 2.5 years:

    • Visual reinforcement audiometry (VRA) 1
  • 2.5 to 4 years:

    • Play audiometry 1
  • 4 years and older:

    • Conventional audiometry 1

Benefits of Early Screening

Universal newborn hearing screening has significantly reduced the age at which hearing loss is identified:

  • Mean age of identification has decreased from 12-13 months to 3-6 months 1
  • Mean age for receiving hearing aids has decreased from 13-16 months to 5-7 months 1
  • Early identification leads to better speech and language outcomes

Special Considerations

  • NICU Infants: Require ABR screening (not just OAE) to detect neural hearing loss 1
  • High-Risk Infants: Even those who pass newborn screening should have at least one diagnostic audiological assessment by 24-30 months 1
  • Specific Risk Factors: Children with CMV infection, ECMO treatment, or certain other risk factors require more frequent audiological assessments 1

Common Challenges

  • Appointment Availability: The most frequently reported challenge to obtaining timely diagnostic evaluation (36% of cases) 3
  • Parent Education: 27% of parents report not feeling comfortable knowing next steps after diagnosis 3
  • False Positives: Can cause parental anxiety; in low-risk populations, there are 25-50 false positives for each true case 1

Pitfalls to Avoid

  1. Delaying Initial Screening: Missing the 1-month window can lead to delayed diagnosis and intervention
  2. Inadequate Follow-up: 13-31% of infants who fail initial screening do not return for definitive testing 1
  3. Screening Method Selection: Using only OAE in NICU infants can miss neural hearing loss
  4. Ignoring Risk Factors: Children with risk factors need ongoing surveillance even if they pass initial screening

Early detection and intervention for hearing loss is critical for optimal language development and quality of life. Following the 1-3-6 guideline (screening by 1 month, diagnosis by 3 months, intervention by 6 months) provides the best outcomes for children with hearing impairment.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.